Concepedia

Author

Hui‐Ling Zhen

Beijing University of Posts and TelecommunicationsORCID

Also Known As

H L Zhen, H. Zhen, HUI-LING ZHEN, Hui-Ling Zhen, Huiling Zhen, Hui‐Ling Zhen, Khan, Sadaf, Young, Evangeline F. Y., Zhen, Hui-Ling, Zhen, Hui-ling

165

Publications

4.4K

Citations

30

H-Index

114

Concepts

All Affiliations

Beijing University of Posts and TelecommunicationsIncyte (United States)Institut Gustave RoussyThe University of Texas MD Anderson Cancer CenterMemorial Sloan Kettering Cancer Center
HZ

About

Hui‐Ling Zhen is an author at Beijing University of Posts and Telecommunications specializing in engineering, physics, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

17

20

692

2

Medicine

12

15

1.9K

3

Health Sciences

3

3

192

4

Business

1

1

57

5

Education

1

1

25

Hui‐Ling Zhen

×

60

Publications

4.1K

Citations

30

H-Index

YearCitations

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque,

The Lancet Oncology

2020

1.5K

Clinicogenomic Analysis of <i>FGFR2</i> -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Ian M. Silverman, Antoine Hollebecque, Luc Friboulet,

Cancer Discovery

2020

269

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with <i>FGFR2</i> rearrangements

Tanios Bekaii‐Saab, Juan W. Valle, Eric Van Cutsem,

Future Oncology

2020

159

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Srđan Verstovšek, A. M. Vannucchi, Tamás Masszi,

Haematologica

2016

156

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko,

Nature

2022

124

A survey for solving mixed integer programming via machine learning

Jiayi Zhang, Chang Liu, Xijun Li,

Neurocomputing

2022

92

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

Ruben A. Mesa, Alessandro M. Vannucchi, Abdulraheem Yacoub,

British Journal of Haematology

2016

86

Optical rogue waves associated with the negative coherent coupling in an isotropic medium

Wen‐Rong Sun, Bo Tian, Yan Jiang,

Physical Review E

2015

63

Breathers and rogue waves of the fifth-order nonlinear Schrödinger equation in the Heisenberg ferromagnetic spin chain

Wen‐Rong Sun, Bo Tian, Hui‐Ling Zhen,

Nonlinear Dynamics

2015

59

FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)

Arndt Vogel, Vaibhav Sahai, Antoine Hollebecque,

Annals of Oncology

2019

59

Page 1